• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Increased Risk of Aspiration Pneumonia Associated With Endoscopic Procedures Among Patients With Glucagon-like Peptide 1 Receptor Agonist Use.

作者信息

Yeo Yee Hui, Gaddam Srinivas, Ng Wee Han, Huang Pin-Chia, Ma Kevin Sheng-Kai, Rezaie Ali

机构信息

Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, California.

Bristol Medical School, University of Bristol, Bristol, United Kingdom.

出版信息

Gastroenterology. 2024 Jul;167(2):402-404.e3. doi: 10.1053/j.gastro.2024.03.015. Epub 2024 Mar 27.

DOI:10.1053/j.gastro.2024.03.015
PMID:38552724
Abstract
摘要

相似文献

1
Increased Risk of Aspiration Pneumonia Associated With Endoscopic Procedures Among Patients With Glucagon-like Peptide 1 Receptor Agonist Use.使用胰高血糖素样肽-1受体激动剂的患者在内镜检查过程中发生误吸性肺炎的风险增加。
Gastroenterology. 2024 Jul;167(2):402-404.e3. doi: 10.1053/j.gastro.2024.03.015. Epub 2024 Mar 27.
2
Association between Glucagon-like Peptide-1 Receptor Agonists and Aspiration Pneumonia during Endoscopic Procedures.胰高血糖素样肽-1受体激动剂与内镜检查期间吸入性肺炎的关联。
Anesthesiology. 2024 Nov 1;141(5):1009-1012. doi: 10.1097/ALN.0000000000005174.
3
Low Incidence of Pulmonary Aspiration During Upper Endoscopy in Patients Prescribed a Glucagon-Like Peptide 1 Receptor Agonist.在接受胰高血糖素样肽 1 受体激动剂治疗的患者中，上消化道内镜检查期间发生肺部吸入的发生率较低。
Clin Gastroenterol Hepatol. 2024 Jun;22(6):1333-1335.e2. doi: 10.1016/j.cgh.2023.11.024. Epub 2023 Dec 2.
4
No pancreatic safety concern following glucagon-like peptide-1 receptor agonist therapies: A pooled analysis of cardiovascular outcome trials.GLP-1 受体激动剂治疗后无胰腺安全性担忧：心血管结局试验的汇总分析。
Diabetes Metab Res Rev. 2018 Nov;34(8):e3061. doi: 10.1002/dmrr.3061. Epub 2018 Sep 14.
5
Risks of peri- and postoperative complications with glucagon-like peptide-1 receptor agonists.胰高血糖素样肽-1 受体激动剂的围手术期并发症风险。
Diabetes Obes Metab. 2024 Aug;26(8):3128-3136. doi: 10.1111/dom.15636. Epub 2024 May 14.
6
Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: An updated meta-analysis of randomized controlled trials.接受胰高血糖素样肽-1 受体激动剂治疗的患者的主要心血管事件、心力衰竭和心房颤动：随机对照试验的更新荟萃分析。
Nutr Metab Cardiovasc Dis. 2020 Jun 25;30(7):1106-1114. doi: 10.1016/j.numecd.2020.03.013. Epub 2020 Mar 25.
7
Glucagon-Like Peptide-1 Receptor Agonism and Suicide Risk: Evidence From Mendelian Randomization.胰高血糖素样肽-1受体激动作用与自杀风险：孟德尔随机化研究证据
J Am Heart Assoc. 2024 Jun 18;13(12):e035948. doi: 10.1161/JAHA.124.035948. Epub 2024 Jun 15.
8
GLP-1 agonist associated acute kidney injury: A case report and review.胰高血糖素样肽-1激动剂相关的急性肾损伤：一例病例报告及文献复习
Diabetes Metab. 2019 Oct;45(5):489-491. doi: 10.1016/j.diabet.2017.12.002. Epub 2017 Dec 9.
9
Pharmacogenetics: Genetic approach supports cardiovascular safety of GLP1R agonists.药物遗传学：遗传学方法支持胰高血糖素样肽-1受体激动剂的心血管安全性。
Nat Rev Cardiol. 2016 Aug;13(8):444. doi: 10.1038/nrcardio.2016.100. Epub 2016 Jun 16.
10
Glucagon-like peptide-1 receptor agonists and risk of breast cancer.胰高血糖素样肽-1受体激动剂与乳腺癌风险
BMJ. 2016 Oct 20;355:i5519. doi: 10.1136/bmj.i5519.

引用本文的文献

1
Peri-Procedural Safety of GLP-1 Receptor Agonists in Elective Endoscopy: A Multicenter Retrospective Cohort Study.GLP-1受体激动剂在择期内镜检查中的围手术期安全性：一项多中心回顾性队列研究
J Clin Med. 2025 Aug 30;14(17):6147. doi: 10.3390/jcm14176147.
2
Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons.胰高血糖素样肽-1受体激动剂的获益-风险评估：对皮肤科医生和整形外科医生的启示
Dermatol Ther (Heidelb). 2025 Sep 9. doi: 10.1007/s13555-025-01537-5.
3
Glucagon-Like Peptide-1 Receptor Agonists and Peri-Procedural Aspiration Risk.
胰高血糖素样肽-1受体激动剂与围手术期误吸风险
J Endocr Soc. 2025 Jul 10;9(9):bvaf088. doi: 10.1210/jendso/bvaf088. eCollection 2025 Sep.
4
2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations on the peri-procedural use of GLP-1/GIP receptor agonists.2025年关于胰高血糖素样肽-1/葡萄糖依赖性促胰岛素多肽受体激动剂围手术期使用的澳大利亚糖尿病学会/澳大利亚和新西兰麻醉医师学会/胃肠病学会澳大利亚分会/澳大利亚肥胖症协会临床实践建议
Anaesth Intensive Care. 2025 Aug 14:310057X251355288. doi: 10.1177/0310057X251355288.
5
GLP-1 Receptor Agonists and Gastrointestinal Endoscopy: A Narrative Review of Risks, Management Strategies, and the Need for Clinical Consensus.胰高血糖素样肽-1受体激动剂与胃肠内镜检查：风险、管理策略及临床共识需求的叙述性综述
J Clin Med. 2025 Aug 7;14(15):5597. doi: 10.3390/jcm14155597.
6
Impact of GLP-1 receptor agonists on upper gastrointestinal endoscopy: an updated systematic review and meta-analysis.胰高血糖素样肽-1受体激动剂对上消化道内镜检查的影响：一项更新的系统评价和荟萃分析。
Surg Endosc. 2025 Jul 9. doi: 10.1007/s00464-025-11962-4.
7
Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning.探索胰高血糖素样肽-1受体激动剂的副作用：以确保其最佳定位。
Diabetes Metab J. 2025 Jul;49(4):525-541. doi: 10.4093/dmj.2025.0242. Epub 2025 Jul 1.
8
Gastrointestinal Motility Effects of GLP-1 Receptor Agonists.胰高血糖素样肽-1受体激动剂对胃肠动力的影响。
Curr Gastroenterol Rep. 2025 Jul 7;27(1):49. doi: 10.1007/s11894-025-00995-3.
9
Glucagon-like-peptide-1 (GLP-1) receptor agonist use and the risk of pulmonary aspiration in patients undergoing surgery.胰高血糖素样肽-1（GLP-1）受体激动剂的使用与手术患者发生肺误吸的风险
Int J Surg. 2025 Jun 1;111(6):4090-4093. doi: 10.1097/JS9.0000000000002425. Epub 2025 May 12.
10
Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: An Obesity Medicine Association (OMA) and expert joint perspective 2025.肥胖儿童的代谢功能障碍相关脂肪性肝病（MASLD）：肥胖医学协会（OMA）与专家联合观点（2025年）
Obes Pillars. 2025 Feb 1;14:100164. doi: 10.1016/j.obpill.2025.100164. eCollection 2025 Jun.